期刊文献+
共找到444篇文章
< 1 2 23 >
每页显示 20 50 100
PCI compared with medical therapy in elderly patients with chronic symptomatic coronary artery disease
1
作者 刘晓堃 傅向华 马宁 《介入放射学杂志》 CSCD 2003年第S1期150-151,共2页
Objective The aim of this study was to assess quality of results of elderly patients with coronary disease after medical or revascularisation therapy. Methods In this study, we enrolled 103 patients aged 75 years or o... Objective The aim of this study was to assess quality of results of elderly patients with coronary disease after medical or revascularisation therapy. Methods In this study, we enrolled 103 patients aged 75 years or older with chronic angina in which 47 patients were assigned coronary angiography and revascularisation and 56 patients with optimised medical therapy. The primary endpoint was quality of life after 6 months, as assessed by questionnaire and the presence of major adverse cardiac events (death, non fatal myocardial infarction, or hospital admission for acute coronary syndrome with or without the need for revascularisation). Results After 6 months follow up, angina severity decreased and measures of quality of life increased in both treatment groups( P <0.05 ); however, these improvements were significantly greater after revascularisation( P <0.01 ). Major adverse cardiac events occurred in 30 ( 53.6% ) of patients in the medical group and 9 ( 19.1% ) in the invasive group ( P <0.01 ).Conclusions Patients aged 75 years or older with angina benefit more from revascularisation than from optimised medical therapy in terms of symptom relief and quality of life. Therefore, these patients should be offered invasive assessment despite their high risk profile followed by revascularisation if feasible. 展开更多
关键词 pci compared with medical therapy in elderly patients with chronic symptomatic coronary artery disease 河北医科大学第二医院 in with
下载PDF
Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease 被引量:1
2
作者 Zvonimir Ostojic Ana Ostojic +1 位作者 Josko Bulum Anna Mrzljak 《World Journal of Cardiology》 2021年第11期599-607,共9页
The prevalence of coronary artery disease(CAD)increases in patients with endstage liver disease,with part of them receiving the percutaneous coronary intervention(PCI)as a treatment option.Dual antiplatelet therapy(DA... The prevalence of coronary artery disease(CAD)increases in patients with endstage liver disease,with part of them receiving the percutaneous coronary intervention(PCI)as a treatment option.Dual antiplatelet therapy(DAPT),a standard of care after PCI,could result in catastrophic consequences in this population.Before PCI and the start of DAPT,it is recommended to assess patient bleeding risk.Based on novel findings,liver cirrhosis does not necessarily lead to a significant increase in bleeding complications.Furthermore,conventional methods,such as the international normalized ratio,might not be appropriate in assessing individual bleeding risk.The highest bleeding risk among cirrhotic patients has a subgroup with severe thrombocytopenia(<50×10^(9)/L)and elevated portal pressure.Therefore,every effort should be made to maintain thrombocyte count above>50×10^(9)/L and prevent variceal bleeding.There is no solid evidence for DAPT in patients with cirrhosis.However,randomized trials investigating short(one month)DAPT duration after PCI with new drug-eluting stents(DES)in a high bleeding risk patient population can be implemented in patients with cirrhosis.Based on retrospective studies(with older stents and protocols),PCI and DAPT appear to be safe but with a higher risk of bleeding complications with longer DAPT usage.Finally,novel methods in assessing CAD severity should be performed to avoid unnecessary PCI and potential risks associated with DAPT.When indicated,PCI should be performed over radial artery using contemporary DES.Complementary medical therapy,such as proton pump inhibitors and beta-blockers,should be prescribed for lower bleeding risk patients.Novel approaches,such as thromboelastography and“preventive”upper endoscopies in PCI circumstances,warn clinical confirmation. 展开更多
关键词 End-stage liver disease CIRRHOSIS Liver transplantation coronary artery disease Percutaneous coronary intervention Antiplatelet therapy
下载PDF
Comparative Nursing Study of Patients Undergoing Coronary Intervention Therapy in Different Ways
3
作者 Qilian He Yuquan Luan +1 位作者 Yanfen Fu Jun Tang 《Journal of Biosciences and Medicines》 2019年第5期203-212,共10页
Purpose: To compare the surgical indicators, perioperative complications and postoperative psychological status of patients with coronary interventional therapy (CIT) by radical artery and femoral artery puncture appr... Purpose: To compare the surgical indicators, perioperative complications and postoperative psychological status of patients with coronary interventional therapy (CIT) by radical artery and femoral artery puncture approaches. Methods: 120 patients with CIT were divided into femoral artery group (FAG) and radial artery group (RAG) according to the operation ways. The interventional operation was performed by the same surgeon team and methods. Data of surgical indicators and perioperative complications were recorded and collected. The psychological questionare survey was made within 48 hours the after surgery by the hospital anxiety and depression scale (HAD), and the results were scored by the psychiatrist. Results: The age, sex, ethnicity, education level, disease type, and combined diseases of the two groups had homogeneity without statistical difference. There was no obvious difference in X-ray exposure time, contrast agent usage and operation time in two ways (P > 0.05). The success rate of one-time catheterization was higher in FAG than in RAG (P Conclusion: CIT via radial artery can reduce the incidence of postoperative complications, postoperative physical discomfort and psychological problems such as anxiety and depression of patients. 展开更多
关键词 NURSING coronary interventionAL therapy (CIT) coronary Arterial Angiography (CAG) Percutaneous coronary intervention (pci) Radical artery FEMORAL artery The Hospital Anxiety and Depression Scale (HAD)
下载PDF
Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era
4
作者 Jennie Han Nadeem Attar 《World Journal of Cardiology》 2021年第8期243-253,共11页
Percutaneous coronary intervention with stenting is followed by a duration of dual antiplatelet therapy(DAPT)to reduce stent thrombosis and avoid target lesion failure.The period of DAPT recommended in international g... Percutaneous coronary intervention with stenting is followed by a duration of dual antiplatelet therapy(DAPT)to reduce stent thrombosis and avoid target lesion failure.The period of DAPT recommended in international guidelines following drug-eluting stent implantation is 12 mo for most patients with acute coronary syndrome,and 6 mo for patients with chronic coronary syndrome or high bleeding risk.The new generation of drug-eluting stents have metallic platforms with thinner struts,associated with significantly less stent thrombosis.Shortened DAPT has been investigated with these stents,with evidence from randomised clinical trials for some individual stents showing non-inferior safety and efficacy outcomes.This has to be balanced by the effect of DAPT on secondary prevention of systemic cardiovascular disease especially in high-risk populations.This review will outline the current evidence for individual stents with regards to DAPT duration for both acute coronary syndrome and chronic coronary syndrome and discuss further directions for research and personalised medicine in this contemporary percutaneous coronary intervention era. 展开更多
关键词 coronary artery disease Drug-eluting stent Percutaneous coronary intervention Dual antiplatelet therapy Stent thrombosis Target lesion revascularization
下载PDF
THR、MHR和NHR对冠状动脉狭窄程度和行PCI的预测价值
5
作者 刘成 刘森 +4 位作者 杨红 金梦龙 刘紫阳 付真彦 马依彤 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2024年第6期948-953,共6页
目的 探讨总胆固醇与高密度脂蛋白胆固醇比值(THR)、单核细胞与高密度脂蛋白胆固醇比值(MHR)和中性粒细胞与高密度脂蛋白胆固醇比值(NHR)对患者冠状动脉狭窄程度和行经皮冠状动脉介入(PCI)治疗的预测价值。方法 回顾性选取2021年6月至2... 目的 探讨总胆固醇与高密度脂蛋白胆固醇比值(THR)、单核细胞与高密度脂蛋白胆固醇比值(MHR)和中性粒细胞与高密度脂蛋白胆固醇比值(NHR)对患者冠状动脉狭窄程度和行经皮冠状动脉介入(PCI)治疗的预测价值。方法 回顾性选取2021年6月至2023年6月在新疆医科大学第一附属医院行冠状动脉造影的患者,严格纳入排除标准筛选,共纳入6 281例患者,分为PCI组和non-PCI组,收集所有患者的临床资料、实验室检查结果及介入治疗资料。采用Pearson相关性分析评估THR、MHR和NHR与冠状动脉狭窄程度之间的关联。使用二元Logistic逐步回归和受试者工作特征(ROC)曲线评估THR、MHR和NHR单一指标和联合指标对冠心病患者行PCI治疗的影响因素和预测价值。结果 与Non-PCI组比较,PCI组年龄偏大,男性占比、患糖尿病占比、THR、MHR、NHR、Gensini评分高于Non-PCI组,既往支架植入比例少于Non-PCI组(P<0.05)。Pearson相关分析结果显示,THR(r=0.351,P<0.001)、MHR(r=0.192,P<0.001)和NHR(r=0.236,P<0.001)水平与冠状动脉狭窄程度的Gensini评分均存在显著正相关关系。多因素Logistic回归结果显示,年龄>50岁、男性、患糖尿病、THR、MHR、NHR是冠心病患者行PCI独立危险因素,既往支架植入史是冠心病患者行PCI的保护因素。ROC曲线结果显示,THR、MHR和NHR三者联合曲线下面积(AUC)最大(AUC=0.809,95%CI:0.798~0.820)。结论 THR、MHR和NHR与冠状动脉狭窄程度具有相关性,对评估冠心病行PCI治疗有较强的临床应用价值。 展开更多
关键词 总胆固醇与高密度脂蛋白胆固醇比值(THR) 单核细胞与高密度脂蛋白胆固醇比值(MHR) 中性粒细胞与高密度脂蛋白胆固醇比值(NHR) 冠状动脉狭窄 经皮冠状动脉介入治疗(pci)
下载PDF
Initial Experience on Anatomical Snuff Box Approach for Coronary Angiogram &Percutaneous Coronary Intervention in a Tertiary Care Center Nepal 被引量:3
6
作者 Ratna Mani Gajurel Ravi Sahi +2 位作者 Hemant Shrestha Sanjeev Thapa Rajaram Khanal 《World Journal of Cardiovascular Diseases》 2018年第12期578-587,共10页
Introduction: Coronary Angiogram and Percutaneous Coronary Interventions are commonly performed via the femoral route. Then, transradial coronary catheterization became a popular & default technique due to less va... Introduction: Coronary Angiogram and Percutaneous Coronary Interventions are commonly performed via the femoral route. Then, transradial coronary catheterization became a popular & default technique due to less vascular access site complications and bleeding as compared to femoral route. Distal puncture of the radial artery through the anatomical snuff box access, however, has recently been shown potential benefit, like comfort to patients and operators, as well as maintenance of blood flow through the superficial palmar arch, in case of radial artery occlusion. Our aim was to evaluate the safety and feasibility of this new approach. Methods: A cross-sectional observational prospective study of patients underwent invasive diagnostic or therapeutic coronary procedures through the distal trans-radial access and traditional radial access. The primary endpoints were to access difficulties and in-hospital access-site related complications. Results: In 2 months, 190 patients underwent coronary procedures, of which 82 (43%) were selected in both distal transradial & traditional radial group. In 2(2.4%) & 3 (3.6%) cases, distal radial & traditional radial access cannulation was unsuccessful respectively (p >0.05). The mean age was 57.7 ± 10 & 57.2 ± 10 years in successful distal transradial & traditional radial cases respectively. There were no any major vascular complications in distal transradial group while there were 2 vascular complications in traditional radial group (p > 0.05). Conclusions: Distal transradial access is feasible and safe in selected cases, when performed by experienced operators. Larger case series and randomized trials are required to determine its efficacy in reducing vascular complications when comparing to the traditional technique. 展开更多
关键词 CAD: coronary artery Disease CAG: coronary ANGIOGRAM pci: PERCUTANEOUS coronary intervention Radial artery: RA
下载PDF
音乐干预联合正念疗法对PCI术治疗冠心病患者的影响
7
作者 王静 李克亚 +1 位作者 户相访 赵康 《齐鲁护理杂志》 2024年第2期16-18,共3页
目的:探讨基于音乐干预联合正念疗法对经皮冠状动脉介入(PCI)治疗冠心病患者的影响。方法:选取2019年1月1日~2020年12月31日在某三甲医院接受PCI治疗的冠心病患者92例,随机分为对照组和观察组各46例;对照组给予常规护理,观察组在常规护... 目的:探讨基于音乐干预联合正念疗法对经皮冠状动脉介入(PCI)治疗冠心病患者的影响。方法:选取2019年1月1日~2020年12月31日在某三甲医院接受PCI治疗的冠心病患者92例,随机分为对照组和观察组各46例;对照组给予常规护理,观察组在常规护理的基础上给予基于音乐干预联合正念疗法的心理干预。比较两组围术期焦虑、抑郁程度[采用汉密顿焦虑量表(HAMA)和汉密顿抑郁量表(HAMD)],术后第7天尼可地尔服用依从性[采用药物治疗依从性评估量表(MMAS-8)],术后第7天生活质量[采用简明健康状况调查问卷(SF-36)]和术后6个月心血管事件发生率。结果:观察组术后第1、7天HAMA、HAMD评分均低于对照组(P<0.05);观察组术后第7天MMAS-8评分高于对照组(P<0.05);观察组术后第7天SF-36评分高于对照组(P<0.05)。结论:基于音乐干预联合正念疗法对PCI治疗冠心病患者有积极影响,能缓解患者围术期焦虑、抑郁情绪,提高患者对尼可地尔服用依从性和生活质量。 展开更多
关键词 冠心病 pci治疗 音乐干预 正念疗法 尼可地尔
下载PDF
八段锦运动疗法对急性心肌梗死患者PCI术后心脏康复的作用探讨 被引量:3
8
作者 张晓玉 何石燃 +2 位作者 卢小清 杨建 刘畅 《中国卫生标准管理》 2023年第21期137-140,共4页
目的 探讨中医运动疗法“八段锦”对急性心肌梗死(acute myocardial infarction,AMI)患者经皮冠状动脉介入术(percutaneous coronary intervention,PCI)后的心脏康复作用,为今后临床应用提供有利的参考价值。方法 选取中山市中医院2022... 目的 探讨中医运动疗法“八段锦”对急性心肌梗死(acute myocardial infarction,AMI)患者经皮冠状动脉介入术(percutaneous coronary intervention,PCI)后的心脏康复作用,为今后临床应用提供有利的参考价值。方法 选取中山市中医院2022年3—9月收治的行PCI术后的AMI患者120例,按照随机数字表法分成两组,治疗组(n=60)应用常规治疗联合八段锦运动疗法,对照组(n=60)应用常规治疗。治疗3个月,比较两组治疗方案的有效性及安全性。结果 治疗后,两组生理角色、生理功能、总体健康感觉、精神角色评分均高于治疗前(P <0.05)。治疗组患者治疗后生理功能、精神角色评分高于对照组(t=-2.211 1,P=0.029 0;t=-1.976 7,P=0.041 7)。两组治疗后左心室舒张末期容积、左心室收缩末期容积和左心室射血分数与治疗前比较,差异有统计学意义(P<0.05)。治疗后,两组左心室舒张末期容积、左心室收缩末期容积和左心室射血分数比较,差异有统计学意义(P <0.05)。治疗组患者治疗后躯体活动受限程度、治疗满意程度、心绞痛发作频率、疾病的认识、心绞痛稳定状态评分均高于对照组,差异有统计学意义(P <0.05)。结论 八段锦有助于改善AMI患者PCI术后的精神状态及心脏功能,减少发生不良事件发生。 展开更多
关键词 八段锦 运动疗法 急性心肌梗死 冠状动脉 经皮冠状动脉介入术 精神状态 不良事件
下载PDF
关于冠心病患者PCI术后双心治疗成本-效果比的临床研究
9
作者 何东方 张丽军 +9 位作者 迟云鹏 李果 鲁楠 张瑜 李艳玮 王森 黄晓蓉 潘若愚 鲍彦平 刘梅颜 《中国卫生标准管理》 2023年第15期68-73,共6页
目的比较冠心病(coronary artery disease,CAD)患者经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后双心治疗与常规治疗的成本-效果,为冠心病患者PCI术后双心治疗提供依据。方法共纳入2021年8月—2023年6月于首都医... 目的比较冠心病(coronary artery disease,CAD)患者经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后双心治疗与常规治疗的成本-效果,为冠心病患者PCI术后双心治疗提供依据。方法共纳入2021年8月—2023年6月于首都医科大学附属北京安贞医院住院行PCI手术治疗的195例CAD患者,随机分为双心治疗组(79例)与常规治疗组(116例)。通过2周,1、3、6、12、18个月随访,比较两种治疗方法的疗效,计算成本-效果比(cost-effectiveness ratio,CER)、增量成本-效果比(incremental cost-effectiveness ratio,ICER)。结果双心治疗组共79例,其中1例因急性冠脉综合征(acute coronary syndrome,ACS)再入院行PCI治疗,有效率为98.73%;常规治疗组116例,10例因ACS再入院,7例行PCI治疗,1例行冠脉造影检查,2例保守治疗,有效率为91.38%,双心治疗组的临床有效率明显高于常规治疗组(P=0.028)。常规治疗组的CER为766.74,双心治疗组CER为713.44,双心治疗的CER显著低于常规治疗。ICER为50.86。结论与常规治疗比较,冠心病患者PCI术后双心治疗有更显著的临床疗效,较低的CER,且有更好的卫生经济学价值。 展开更多
关键词 pci 冠心病 双心治疗 卫生经济学 成本-效果比 增量成本-效果比
下载PDF
加味温胆汤联合黛力新治疗冠心病PCI术后焦虑抑郁患者的临床疗效及对Lp-PLA2的影响研究 被引量:6
10
作者 徐留刚 王雅君 《广州中医药大学学报》 CAS 2023年第6期1342-1348,共7页
【目的】观察加味温胆汤治疗冠心病冠状动脉支架植入术(PCI)后并发焦虑抑郁患者的临床疗效及其对血清脂蛋白磷脂酶A2(Lp-PLA2)的影响。【方法】将60例冠心病PCI术后伴有焦虑抑郁状态,中医证型为痰浊闭阻证的患者随机分为对照组和观察组... 【目的】观察加味温胆汤治疗冠心病冠状动脉支架植入术(PCI)后并发焦虑抑郁患者的临床疗效及其对血清脂蛋白磷脂酶A2(Lp-PLA2)的影响。【方法】将60例冠心病PCI术后伴有焦虑抑郁状态,中医证型为痰浊闭阻证的患者随机分为对照组和观察组,每组各30例。所有患者均给予冠心病PCI术后常规西药治疗,对照组同时给予黛力新(氟派噻吨美利曲辛片)口服及心理干预治疗(包括健康教育、语言安慰及运动疗法等),治疗组在对照组的基础上联合加味温胆汤治疗,2周为1个疗程,共治疗4个疗程。观察2组患者治疗前后汉密尔顿焦虑量表(HAMA)评分、汉密尔顿抑郁量表(HAMD)评分、中医证候积分及血清Lp-PLA2水平的变化情况,并评价2组患者的中医证候疗效和焦虑抑郁症状改善疗效。【结果】(1)中医证候疗效方面,治疗后,观察组的总有效率为93.33%(28/30),对照组为76.67%(23/30),组间比较,观察组的中医证候疗效明显优于对照组(P<0.05)。(2)焦虑抑郁症状改善疗效方面,治疗后,观察组焦虑、抑郁症状改善疗效的总有效率分别为93.33%(28/30)、96.67%(29/30),对照组均为76.67%(23/30),组间比较,观察组的焦虑、抑郁症状改善疗效均优于对照组(P<0.05)。(3)量表评分方面,治疗后,2组患者的HAMA评分、HAMD评分和中医证候积分均较治疗前明显下降(P<0.01),且观察组的下降幅度均明显优于对照组(P<0.05或P<0.01)。(4)血清Lp-PLA2水平方面,治疗后,2组患者的血清Lp-PLA2水平均较治疗前明显下降(P<0.01),且观察组的下降幅度明显优于对照组(P<0.01)。【结论】加味温胆汤有助于缓解冠心病PCI术后患者焦虑抑郁状态,减轻中医临床症状,改善患者预后,提高患者生活质量,其机制可能与降低血清Lp-PLA2水平,减轻炎性细胞浸润有关。 展开更多
关键词 冠心病 冠状动脉支架植入术后 焦虑 抑郁 痰浊闭阻证 加味温胆汤 黛力新 脂蛋白磷脂酶A2(Lp-PLA2)
下载PDF
Long-term effect of stenting in unprotected left main coronary artery disease in the elderly 被引量:1
11
作者 Caiyi LU Shiwen WANG +8 位作者 Lingling LIU Qiao XUE Xinli WU Taohong HU Pingshuan DONG Zhiping WANG Shenfang TIAN Pinfa LIU Jicai ZANG 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2005年第4期218-222,共5页
Objective To evaluate the feasibility,safety and efficacy of percutaneous stent implantation for treating left main coronary artery(LMCA)stenosis.Methods Consecutive patients with unprotected left main coronary artery... Objective To evaluate the feasibility,safety and efficacy of percutaneous stent implantation for treating left main coronary artery(LMCA)stenosis.Methods Consecutive patients with unprotected left main coronary artery disease treated by stent-based percutaneous intervention(PCI)at 6 medical centers in China were enrolled.Procedural data and clinical outcomes were obtained from all patients.Results From January 2001 to December 2004,138 patients(79 males and 59 females;mean age:69.7±5.8 years)underwent PCI for LMCA stenosis.Bare metal stents(BMS)were implanted in 51 patients with non-bifurcational lesions and in 5 patients with bifurcational lesions from January of 2001 to June of 2003(BMS group);.Drug eluting stents(DES)were used unselectively to cover both bifurcational and non-bifurcational lesions in 86 patients from July of 2003 to December of 2004(DES group).Procedural success rate of the 138 cases was 98%(135/138).One patient(0.7%)with bifurcation lesion who was treated with DES died from severe heart failure 2 weeks after the procedure.During a mean follow up period of 21.3±5.6 months,one patient died from renal failure,one from sudden cardiac death,4 underwent target lesion revascularization(TLR)in the BMS group,which all occurred in patients with bifurcational lesions;whereas in the DES group no deaths occurred and only one patient with bifurcational lesion had TLR.Conclusions(1)PCI is feasible and relatively safe to treat unprotected left main coronary artery disease in elderly patients at medical centers with experienced professionals.(2)BMS and DES have similar immediate and long-term efficacy in the treatment of ostium and shaft lesions of the LMCA.(3)DES are strongly suggested in the therapy of distal bifurcation lesion of unprotected LMCA. 展开更多
关键词 coronary artery disease interventional therapy angioplasty stent
下载PDF
OPT-CAD评分对行直接PCI术后急性心肌梗死患者缺血事件风险的预测研究 被引量:7
12
作者 徐颖 裘淼涵 +5 位作者 祁子钊 张晨松 李晶 王效增 韩雅玲 李毅 《中国现代医学杂志》 CAS 北大核心 2023年第15期87-92,共6页
目的评价中国冠状动脉疾病患者的最佳抗血小板治疗(OPT-CAD)评分对接受直接经皮冠状动脉介入治疗(PCI)的急性心肌梗死(AMI)患者出院后12个月缺血事件风险的预测价值。方法选取2016年3月—2019年3月由中国人民解放军北部战区总医院心血... 目的评价中国冠状动脉疾病患者的最佳抗血小板治疗(OPT-CAD)评分对接受直接经皮冠状动脉介入治疗(PCI)的急性心肌梗死(AMI)患者出院后12个月缺血事件风险的预测价值。方法选取2016年3月—2019年3月由中国人民解放军北部战区总医院心血管内科收治的1953例AMI行直接PCI患者为研究对象。根据OPT-CAD评分进行分组,将患者分为低风险组(OPT-CAD评分<90分)541例和中高风险组(OPT-CAD评分≥90分)1412例。所观察的主要结局事件是出院后12个月内的缺血事件,包括心源性死亡、心肌梗死及卒中。次要结局事件为12个月内缺血事件的各独立组成成分及全因死亡。绘制受试者工作特征(ROC)曲线,评价OPT-CAD评分对患者院后12个月内(出院后3、6、9、12个月)缺血事件的预测价值。结果与低风险组患者比较,中高风险组患者12个月的缺血事件、心源性死亡及全因死亡发生率显著增加(P<0.05)。OPT-CAD评分预测患者出院后3、6、9、12个月缺血事件的曲线下面积(AUC)分别为0.767(95%CI:0.701,0.832)、0.769(95%CI:0.709,0.828)、0.756(95%CI:0.700,0.812)、0.764(95%CI:0.710,0.818),均>0.75。OPT-CAD评分预测患者出院后3个月缺血事件的临界值为125分,敏感性为71%(95%CI:0.596,0.827),特异性为73%(95%CI:0.707,0.747);6个月缺血事件的临界值为124分,敏感性为72%(95%CI:0.614,0.827),特异性为72%(95%CI:0.696,0.737);9个月缺血事件的临界值为123分,敏感性为71%(95%CI:0.609,0.806),特异性为70%(95%CI:0.680,0.721);12个月缺血事件的临界值为123分,敏感性为71%(95%CI:0.626,0.816),特异性70%(95%CI:0.681,0.723)。结论OPT-CAD评分可以准确且稳定地预测行直接PCI的AMI患者出院后12个月内缺血事件的风险。 展开更多
关键词 中国冠状动脉疾病患者的最佳抗血小板治疗评分 急性心肌梗死 经皮冠状动脉介入治疗
下载PDF
Clinical follow up of patients with premature coronary artery disease (PCAD) implanted with drug-eluting stents
13
作者 Xiaofeng Zhang Yong Tang +1 位作者 Genshan Ma Zhong Chen 《World Journal of Cardiovascular Diseases》 2013年第4期329-335,共7页
Background: Drug-eluting stents (DESs) are associated with lower restenosis rates. However, minimal data on the follow up results of premature coronary artery disease (PCAD) treated with DESs exist. This study was to ... Background: Drug-eluting stents (DESs) are associated with lower restenosis rates. However, minimal data on the follow up results of premature coronary artery disease (PCAD) treated with DESs exist. This study was to evaluate clinical characteristics and one- year prognosis of PCAD implanted with DESs in a Chinese population. Methods: 282 patients with PCAD, of which 177 implanted with DESs and 105 prescribed medicine alone were enrolled and analyzed. Major adverse cardiovascular events (MACEs) and the use of medications for secondary prevention were collected and analyzed. Results: Compared with those receiving medicine alone, patients implanted with DESs had higher ratios of males than females, they also had acute coronary syndromes, multi-vessel disease, higher values of cardiac troponin I, longer hospital stays, higher aspirin and clopidogrel use (all P β-blockers and statins use during follow-up, they had higher ratios of recurrent angina and composite MACEs during one-year follow- up (all P y syndrome (OR 1.716, 95% CI: 1.011 - 2.913) and reduced left ventricular ejection fraction (OR 2.539, 95% CI: 1.180 - 5.463) predict MACEs in a one-year follow-up among patients with PCAD. Conclusions: PCAD patients implanted with DESs have more unstable clinical phenotypes and higher MACEs during a one-year follow-up period, though they were prescribed higher ratios of optimal therapeutic medicine. Further enhanced strategies should be made for secondary prevention. 展开更多
关键词 coronary artery Disease Optimal Medicine therapy PERCUTANEOUS coronary intervention Secondary Prevention Major ADVERSE Cardiac Events
下载PDF
肌钙蛋白、SNYTAX积分、GRACE评分与老年冠心病PCI术后再次血运重建的关系 被引量:2
14
作者 周晓丹 王岩 +3 位作者 项军 项楚涵 田静 潘德锋 《疑难病杂志》 CAS 2023年第8期824-828,共5页
目的探讨肌钙蛋白I(cTnI)、SNYTAX积分、全球急性冠状动脉疾病登记(GRACE)评分与老年冠心病PCI术后再次血运重建的关系。方法选取2016年1月-2021年1月中国人民解放军陆军第七十一集团军医院心血管内科收治PCI治疗老年冠心病患者300例,基... 目的探讨肌钙蛋白I(cTnI)、SNYTAX积分、全球急性冠状动脉疾病登记(GRACE)评分与老年冠心病PCI术后再次血运重建的关系。方法选取2016年1月-2021年1月中国人民解放军陆军第七十一集团军医院心血管内科收治PCI治疗老年冠心病患者300例,基于PCI术后冠状动脉造影检查结果是否需要再次血运重建分为再次血运重建组(A组)91例和非再次血运重建组(B组)209例。比较2组患者临床资料及cTnI、SNYTAX积分、GRACE评分,Logistic回归分析再次血运重建影响因素,受试者工作特征曲线(ROC)分析cTnI、SNYTAX积分、GRACE评分诊断再次血运重建的效能。结果A组cTnI水平、SNYTAX积分、GRACE评分高于B组(t=4.802、10.080、8.744,P均<0.001),cTnI高、SNYTAX积分高、GRACE评分高均是影响再次血运重建的危险因素[OR(95%CI)=7.581(1.655~9.558)、2.585(2.055~5.065)、1.832(1.234~4.276)];ROC曲线分析显示,高cTnI、SNYTAX积分、GRACE评分及三者联合检测的曲线下面积(AUC)分别为0.628、0.802、0.795、0.876,三者联合优于各自单独预测价值(Z=6.823、3.064、3.589,P均<0.001)。结论cTnI、SNYTAX积分、GRACE评分与老年冠心病PCI术后再次血运重建有关,上述指标联合检测可作为再次血运重建预测指标。 展开更多
关键词 冠心病 经皮冠状动脉介入 再次血运重建 肌钙蛋白I SNYTAX积分 全球急性冠状动脉疾病登记评分 预测价值 老年人
下载PDF
急性心肌梗死冠脉介入治疗前TyG及心率变异性的监测价值及预后影响因素分析
15
作者 李志 邬春梦 雷锐 《临床和实验医学杂志》 2024年第17期1814-1818,共5页
目的 探讨急性心肌梗死(AMI)冠脉介入治疗前后甘油三酯葡萄糖指数(TyG)及心率变异性的监测价值及预后影响因素。方法 选取2020年3月到2023年3月佳木斯市中心医院收治的90例AMI患者进行回顾性分析,所有患者均采取冠脉介入治疗,对所有患... 目的 探讨急性心肌梗死(AMI)冠脉介入治疗前后甘油三酯葡萄糖指数(TyG)及心率变异性的监测价值及预后影响因素。方法 选取2020年3月到2023年3月佳木斯市中心医院收治的90例AMI患者进行回顾性分析,所有患者均采取冠脉介入治疗,对所有患者进行1年门诊复查随访,分析其治疗情况及预后,并对比其治疗前后TyG及心率变异性变化,建立受试者操作特征(ROC)曲线,分析治疗后TyG及心率变异性指标对AMI后不良心血管事件的诊断价值。随后将术后1年发生心血管不良事件的20例患者分为预后不良组,其余为预后良好组。多因素Logistics回归分析影响AMI介入治疗预后的因素。结果 90例AMI患者27例行急诊PCI,63例行择期PCI,单支血管病变患者42例,2支及以上48例,通过对患者进行1年随访,20例患者发生不良心血管事件。治疗后TyG为7.28±1.49,低于治疗前,治疗后全程相邻R-R间期差值均方根值(rMSSD)、全部正常窦性心搏R-R间期标准差(SDNN)及5 min心搏间期均值标准差(SDANN)分别为(37.62±6.24) ms、(120.51±12.37) ms、(126.62±16.66) ms,均高于治疗前,差异均有统计学意义(P<0.05)。TyG联合心率变异性指标的诊断敏感度为71.57%,特异度为83.56%,联合诊断明显高于单一指标诊断;预后良好组与预后不良组患者性别、体重指数、饮酒史、PCI治疗时机、左心室射血分数、预后危险(TIMI)评分比较,差异均无统计学意义(P>0.05),预后良好组与预后不良组患者年龄、发病到PCI时间、合并基础疾病、Killip心功能分级、吸烟史、冠脉病变支数、TIMI评分、TyG、rMSSD、SDNN、SDANN比较,差异均有统计学意义(P<0.05)。结果显示,年龄、发病到PCI时间、Killip心功能分级、TyG、rMSSD、SDNN、SDANN是影响AMI介入治疗预后的独立危险因素(P<0.05)。结论 AMI采取冠脉介入治疗术后1年不良心血管事件发生率达22.22%,通过冠脉介入治疗可降低患者机体TyG水平,改善心率变异性;治疗后采用TyG联合心率变异性指标和提升对不良心血管事件的诊断价值;进一步分析发现,年龄、发病到PCI时间、Killip心功能分级、TyG及心率变异性为其预后不良的影响因素。 展开更多
关键词 甘油三酯葡萄糖指数 心率变异性 急性心肌梗死 冠状动脉介入治疗
下载PDF
Interventional therapy of coronary artery disease in China: retrospective and perspective 被引量:6
16
作者 SHEN Wei-feng 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第22期2336-2341,共6页
Coronary artery disease is the most common cardiovascular disease and constitutes the major cause of death in China. The interventional treatment of coronary artery disease has developed rapidly during the last decade... Coronary artery disease is the most common cardiovascular disease and constitutes the major cause of death in China. The interventional treatment of coronary artery disease has developed rapidly during the last decade, with the number of percutaneous coronary intervention (PCI) procedures being around 147 300 in the year of 2007. The number is expected to be elevated greatly in the coming years because of great improvement in national health care system and interventional expertise This article reviews the current status of coronary intervention in China. 展开更多
关键词 coronary artery disease interventional therapy
原文传递
出院后药学干预对基层医院PCI术后冠心病患者用药依从性及其预后的影响 被引量:31
17
作者 周树军 王云梅 +4 位作者 王振娟 张立强 孔令军 宗文仓 娄志刚 《中国药房》 CAS 北大核心 2017年第8期1126-1129,共4页
目的:探讨出院后药学干预对基层医院经皮冠状动脉介入术(PCI)术后冠心病患者用药依从性及其预后的影响。方法:选取2012年1月-2015年5月于我院行PCI的冠心病患者180例,根据其是否接受出院后药学干预分为试验组和对照组,各90例。对照组患... 目的:探讨出院后药学干预对基层医院经皮冠状动脉介入术(PCI)术后冠心病患者用药依从性及其预后的影响。方法:选取2012年1月-2015年5月于我院行PCI的冠心病患者180例,根据其是否接受出院后药学干预分为试验组和对照组,各90例。对照组患者给予常规药学服务和出院教育;试验组患者在此基础上,给予出院后药学干预(包括建立药学服务档案、电话随访、患者教育等),比较出院后1年内两组患者的用药依从性和心血管事件的发生情况。结果:出院后1年内,试验组用药依从的患者比例显著高于对照组,部分依从和不依从的患者比例显著低于对照组;试验组患者1年内心力衰竭和再次血运重建的发生率、住院病死率和全因死亡率均显著低于对照组,差异均有统计学意义(P<0.05)。结论:出院后药学干预可提高基层医院PCI术后冠心病患者的用药依从性,减少心血管事件的发生,改善其临床预后。 展开更多
关键词 出院后药学干预 基层医院 冠心病 经皮冠状动脉介入术 用药依从性 预后
下载PDF
网织血小板与早发冠心病PCI术后远期预后的相关性 被引量:12
18
作者 张岩 王聪霞 +6 位作者 刘晓唤 张春艳 胡艳超 马维冬 贾珊 李永勤 韩振华 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2018年第3期327-331,共5页
目的探讨网织血小板(reticulated platelets,RPs)与早发冠状动脉疾病(premature coronary artery disease,PCAD)经皮冠状动脉介入术(percutaneous coronary intervention,PCI)后远期预后的相关性。方法共纳入300例PCAD患者(冠心病发病... 目的探讨网织血小板(reticulated platelets,RPs)与早发冠状动脉疾病(premature coronary artery disease,PCAD)经皮冠状动脉介入术(percutaneous coronary intervention,PCI)后远期预后的相关性。方法共纳入300例PCAD患者(冠心病发病年龄男性<45岁,女性<55岁)及冠脉造影正常者250例为对照组。用双标记流式细胞仪对全血进行检测获得RPs百分比(RPs%)。随访24月时,评估RPs与远期主要不良心脏血管事件(major adverse cardiac event,MACE)及冠脉支架内再狭窄(in-stent restenosis,ISR)的相关性。结果随访24月共发生MACE 20例(占6.7%)。PCAD组与对照组的吸烟、糖尿病、家族史、心力衰竭史差异均有统计学意义;PCAD组RPs显著高于对照组,差异有统计学意义(P<0.05)。RPs>10%组ISR的发生率与RPs 6%~8%组的差异有统计学意义(P<0.05)。Cox比例风险回归分析RPs>10%是预测心脏不良事件的一个独立变量(HR=2.58,95%可信区间:1.12~5.35,P<0.01)。Kaplan-Meier事件生存率曲线显示,RPs>10%组的心血管事件发生率高于RPs<10%组。结论 RPs是预测PCAD行PCI术后远期预后的独立分子标志物。RPs>10%与PCAD患者PCI术后ISR相关,且MACE发生率高。 展开更多
关键词 网织血小板 早发冠心病 远期预后 支架内再狭窄 经皮冠状动脉介入术(pci)
下载PDF
替格瑞洛在老年STEMI患者急诊PCI中的疗效与安全性分析 被引量:78
19
作者 许骥 华琦 +4 位作者 胡少东 刘志 李博宇 桑成 夏经钢 《首都医科大学学报》 CAS 北大核心 2015年第1期73-77,共5页
目的观察替格瑞洛在老年急性ST段抬高型心肌梗死(ST-segment elevated myocardial infarction,STEMI)患者急诊经皮冠状动脉介入治疗术(percutaneous coronary artery intervention,PCI)中的疗效和安全性。方法 2013年4月至2014年10月行... 目的观察替格瑞洛在老年急性ST段抬高型心肌梗死(ST-segment elevated myocardial infarction,STEMI)患者急诊经皮冠状动脉介入治疗术(percutaneous coronary artery intervention,PCI)中的疗效和安全性。方法 2013年4月至2014年10月行急诊PCI术的60岁以上STEMI患者113例,采用数字表法随机分为负荷量替格瑞洛组(57例)和氯吡格雷组(56例),分别给予300 mg阿司匹林和180 mg替格瑞洛嚼服及300 mg阿司匹林和600 mg氯吡格雷嚼服。观察并比较2组患者急诊PCI术后无复流情况及术后1个月内主要心脏不良事件(major adverse cardiovascular events,MACE)发生率及出血、呼吸困难及恶性心律失常的发生率。结果替格瑞洛组无复流发生率以及术后1个月MACE的发生率均低于氯吡格雷组(P<0.05);而2组主要出血、恶性心律失常的发生率差异无统计学意义(P>0.05)。结论在老年STEMI患者的急诊PCI治疗中,应用替格瑞洛抗栓疗效显著,且安全性较好。 展开更多
关键词 替格瑞洛 氯吡格雷 抗血小板 急性ST段抬高型心肌梗死 经皮冠状动脉介入术
下载PDF
直接冠脉内注射替罗非班在急性心肌梗死患者急诊PCI中治疗疗效的研究 被引量:27
20
作者 尤威 叶飞 +3 位作者 陈绍良 田乃亮 张俊杰 徐兢 《安徽医药》 CAS 2013年第7期1209-1211,共3页
目的探讨在急性心肌梗死(包括ST段抬高及非ST段抬高心肌梗死)患者行急诊PCI的过程中,冠脉内注射替罗非班继之静脉内持续泵入使用的安全性,以及能否进一步改善患者的急诊PCI疗效及减少术后近期心血管事件的发生率。方法回顾性分析2008年1... 目的探讨在急性心肌梗死(包括ST段抬高及非ST段抬高心肌梗死)患者行急诊PCI的过程中,冠脉内注射替罗非班继之静脉内持续泵入使用的安全性,以及能否进一步改善患者的急诊PCI疗效及减少术后近期心血管事件的发生率。方法回顾性分析2008年12月—2010年12月,37例急性心肌梗死患者行急诊PCI治疗时冠脉内注射了替罗非班继之静脉持续维持,另将同期的37例急性心肌梗死行急诊PCI时仅静脉内使用替罗非班的患者作为对照组,比较两组间的基础临床状况,术前术后梗死相关血管(IRA)的TIMI血栓积分(TIMI Thrombus Score)、TIMI血流分级(TIMI Flow Grades)、校正的TIMI血流帧数计数(Corrected TIMI Frame Count)、TIMI心肌灌注(TIMI Myocardial Perfusion)情况以及术后90 min心电图ST段回落百分比(sum-STR),以及住院期间主要心血管事件、出血事件及左室射血分数等。结果两者基础临床情况差异无显著性(P>0.05),冠脉内注射替罗非班继之静脉维持组术后达到TMP分级2级以上获得率(分别为94.6%和67.6%,P=0.003)、校正的TIMI帧数<25帧获得率(分别为91.9%和64.9%,P=0.005)、术后90 min心电图ST段回落百分比(sumSTR)(分别为67.6%和27.0%,P=0)、术后1周的射血分数[(56.62±6.897)和(51.59±6.817),P=0.002)]高于对照组,而两组的TIMI 3级血流的获得率以及两组住院期间的主要心血管事件发生率、出血事件发生率差异无显著性(P>0.05)。结论在急性心肌梗死患者行急诊PCI治疗中冠脉内注射替罗非班继之静脉维持是安全的,可以提高心肌微血管水平的灌注,从而改善患者的短期临床预后,长期预后情况仍需进一步研究。 展开更多
关键词 替罗非班 急性心肌梗死 经皮冠状动脉介入治疗 梗死相关血管
下载PDF
上一页 1 2 23 下一页 到第
使用帮助 返回顶部